title: Zolpidem in Parkinson's disease.
authors.forename: A
authors.initials: A
authors.lastname: Daniele
authors.forename: A
authors.initials: A
authors.lastname: Albanese
authors.forename: G
authors.initials: G
authors.lastname: Gainotti
authors.forename: B
authors.initials: B
authors.lastname: Gregori
authors.forename: P
authors.initials: P
authors.lastname: Bartolomeo
mesh_terms: D000978:Antiparkinson Agents / Q000627:therapeutic use*; D018592:Cross-Over Studies; D004311:Double-Blind Method; D005260:Female; D005917:Globus Pallidus / Q000187:drug effects; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D008875:Middle Aged; D009048:Motor Skills / Q000187:drug effects / Q000502:physiology; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology; D010919:Placebos; D011725:Pyridines / Q000627:therapeutic use*; D018079:Receptors, GABA / Q000187:drug effects; D013378:Substantia Nigra / Q000187:drug effects; D000077334:Zolpidem
chemical_list: D000978:Antiparkinson Agents; D006993:Hypnotics and Sedatives; D010919:Placebos; D011725:Pyridines; D018079:Receptors, GABA; D000077334:Zolpidem